A Multi-domain Protein System Based on the HCFragment of Tetanus Toxin for Targeting DNA to Neuronal Cells
- 1 July 2003
- journal article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 11 (6) , 333-343
- https://doi.org/10.1080/1061186310001634667
Abstract
One goal of gene therapy is the targeted delivery of therapeutic genes to defined tissues. One attractive target is the central nervous system as there are several neuronal degenerative diseases which may be amenable to gene therapy. At present there is a lack of delivery systems that are able to target genes specifically to neuronal cells. Multi-domain proteins were designed and constructed to facilitate the delivery of exogenous genes to neuronal cells. Neuronal targeting activity of the proteins was achieved by inclusion of the HC fragment of tetanus toxin (TeNT), a protein with well-characterised tropism for the central nervous system. The yeast Gal4 DNA-binding domain enabled specific binding of DNA while the translocation domain from diphtheria toxin (DT) was included to facilitate crossing of the endosomal vesicle. One multi-domain protein, containing all three of these domains, was found to transfect up to 8% of neuroblastoma N18-RE105 cells with marker genes. Monitoring the transfection by confocal microscopy indicated that this protein-DNA transfection complex is to some extent localised at the cell surface, suggesting that further improvements to translocating this membrane barrier may yield higher transfection levels. The demonstration that this multi-domain protein can target genes specifically to neuronal cells is a first step in the development of novel vectors for the delivery of genes with therapeutic potential to diseased neuronal tissues.Keywords
This publication has 23 references indexed in Scilit:
- Gene therapy in the CNSGene Therapy, 2000
- Gene therapy for genetic diseasesPediatrics International, 1998
- Delivery of Recombinant Tetanus–Superoxide Dismutase Proteins to Central Nervous System Neurons by Retrograde Axonal TransportExperimental Neurology, 1997
- Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenovirusesJournal of Virology, 1997
- Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.Proceedings of the National Academy of Sciences, 1995
- Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus VectorsHuman Gene Therapy, 1994
- Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectorsNature Genetics, 1993
- Transfer of a foreign gene into the brain using adenovirus vectorsNature Genetics, 1993
- Neuronal lysosomal enzyme replacement using fragment C of tetanus toxin.Proceedings of the National Academy of Sciences, 1992
- AN ANTIGENIC POLYPEPTIDE FRAGMENT ISOLATED FROM TETANUS TOXIN: CHEMICAL CHARACTERIZATION, BINDING TO GANGLIOSIDES AND RETROGRADE AXONAL TRANSPORT IN VARIOUS NEURON SYSTEMSJournal of Neurochemistry, 1977